Research

State and federal spending on prescription drugs is dramatically outpacing inflation, even after accounting for rebates, according to a new analysis of federal data.

Overview of potential best sellers for 2020.

Disease Burden, Costs and Access to Medicines

40 million people with diabetes globally will be left without insulin by 2030.

A ‘ripple effect’ analysis of cancer’s wider impact.

Anticancer Drug Prices and Clinical Outcomes: A cross-sectional study in Italy.

If Americans were to match the average prices of prescription medications in the UK, Canada, and Japan, there would be a 70% drop in drug spending. Holy economic opportunity!

With a list price of $225,000 per year, tafamidis is the most expensive cardiovascular drug on the market.

Up to 25% of health spending in the US is wasteful. Where is that money being lost? What can we do about it?

Much is made of the cost of drugs in the U. S., a topic that is in the crosshairs of both political parties.

In the U.S. health care system, 1% of patients account for almost 25% of all health care spending.

Many hospital and insurance executives have pinned their hopes on this research because it promised to solve a common problem.

Here are four kinds of stories you can do using ProPublica’s interactive database, Dollars for Profs.

Cost Drivers and Strategies to Address Them

New medicines represent an increasingly important segment of the global pharmaceutical market.